New diabetes clinical trial: A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 2 Diabetes
Published on: May 16, 2019 at 09:30PM
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: LY900014; Drug: Insulin Lispro; Drug: Insulin Glargine; Drug: Insulin Degludec
Sponsor: Eli Lilly and Company
Not yet recruiting
http://bit.ly/2HrCAPJ
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: LY900014; Drug: Insulin Lispro; Drug: Insulin Glargine; Drug: Insulin Degludec
Sponsor: Eli Lilly and Company
Not yet recruiting
http://bit.ly/2HrCAPJ
0 Comments